Alumis (ALMS) said Tuesday its shareholders approved its pending merger with Acelyrin (SLRN) at a special shareholder meeting.
Separately, Acelyrin also said its stockholders approved its merger agreement with Alumis at a special meeting. Acelyrin stockholders will receive 0.4814 shares of Alumis stock for each Acelyrin share.
They expect to close the merger in the second quarter.
Price: 4.83, Change: -0.42, Percent Change: -8.00
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。